Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib

被引：9
|
作者：
Xia, Dengmei [1 ,2 ]
Xiao, Yue [1 ]
Li, Mengmeng [1 ]
Li, Wei [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Dermatol, Rare Dis Ctr, 37 Guo Xue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Sichuan, Peoples R China
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 09期
关键词：
D O I：
10.1111/dth.15724
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Treatment of atopic dermatitis with biologics and Janus kinase inhibitors
    Thyssen, Jacob P.
    Thomsen, Simon F.
    LANCET, 2021, 397 (10290): : 2126 - 2128
  • [42] Baricitinib, an oral, reversible Janus kinase-1 and-2 inhibitor, for atopic dermatitis: Head and neck response from BREEZE-AD5
    Bissonnette, Robert
    Korman, Neil
    Lockshin, Benjamin
    Lu, Na
    Chen, Yun-Fei
    Goldblum, Orin
    Rueda, Jose
    Poulin, Yves
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB91 - AB91
  • [43] Oclacitinib, a novel Janus kinase inhibitor for the treatment of atopic dermatitis and other case of pruritus in dogs
    Akos, Jerzsele
    Dora, Kovacs
    Zoltan, Somogyi
    MAGYAR ALLATORVOSOK LAPJA, 2017, 139 (09) : 545 - 552
  • [44] Effective treatment of refractory lichen planus pemphigoides with a Janus kinase-1/2 inhibitor
    Moussa, Anthony
    Colla, Themis Getsos
    Asfour, Leila
    Bhoyrul, Bevin
    Sinclair, Rodney D.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) : 2040 - 2041
  • [45] Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model
    Yamamoto, Yasuo
    Otsuka, Atsushi
    Nakashima, Chisa
    Ishida, Yoshihiro
    Honda, Tetsuya
    Egawa, Gyohei
    Amano, Wataru
    Usui, Kenji
    Hamada, Yuji
    Wada, Masashi
    Tanimoto, Atsuo
    Konishi, Noriko
    Hayashi, Mikio
    Matsushita, Mutsuyoshi
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 97 (02) : 161 - 164
  • [46] Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor
    Yang, Jianqiu
    Yuan, Chunyu
    Zhou, Shengru
    Teng, Zhicheng
    Li, Min
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 529 - 537
  • [47] Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib
    Dasari, S. R.
    Seelam, N.
    Jayachandra, S.
    Vadali, L. R.
    Yerva, E. R.
    Tondepu, S.
    Gadakar, M. K.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2019, 55 (10) : 1569 - 1574
  • [48] A case of widespread molluscum contagiosum caused by baricitinib, a Janus kinase inhibitor
    Wong, Gwyneth Natalie
    Lee, Senhong
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (04) : E334 - +
  • [49] Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib
    De Stefano, Ludovico
    Bobbio-Pallavicini, Francesca
    Montecucco, Carlomaurizio
    Bugatti, Serena
    RHEUMATOLOGY, 2022, 61 (03) : E64 - E66
  • [50] Synthesis and Characterization of Compounds Potentially Related to the Janus Kinase Inhibitor Baricitinib
    S. R. Dasari
    N. Seelam
    S. Jayachandra
    L. R. Vadali
    E. R. Yerva
    S. Tondepu
    M. K. Gadakar
    Russian Journal of Organic Chemistry, 2019, 55 : 1569 - 1574
12345